SCHEMBL20215005

SCHEMBL20215005

CC(C)(C)OC(=O)Nc1cccc(C[C@H](N)CN)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AURKA O14965 1/20 0.47
RPS6KB1 P23443 1/20 0.47
SLC7A5 Q01650 1/20 0.45
NOS3 P29474 1/20 0.44
NOS1 P29475 1/20 0.44
NOS2 P35228 1/20 0.44
SIRT2 Q8IXJ6 1/20 0.43
NPY1R P25929 1/20 0.43
HDAC1 Q13547 2/20 0.42
HDAC3 O15379 1/20 0.42
HDAC2 Q92769 1/20 0.42
HDAC8 Q9BY41 1/20 0.42
HDAC6 Q9UBN7 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2C19 P33261 1/20 0.42
CYP17A1 P05093 1/20 0.42
PRMT5 O14744 1/20 0.41
WDR77 Q9BQA1 1/20 0.41
PDK1 Q15118 1/20 0.41
PDK2 Q15119 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16856591 0.90 AURKA (0.47) AURKARPS6KB1SLC7A5NOS3NOS1
SCHEMBL20204195 0.90 AURKA (0.47) AURKARPS6KB1SLC7A5NOS3NOS1
SCHEMBL20204198 0.88 AURKA (0.46) AURKARPS6KB1SLC7A5NOS3NOS1
SCHEMBL18179951 0.88 AURKA (0.46) AURKARPS6KB1SLC7A5NOS3NOS1
SCHEMBL2367233 0.85 SLC7A5 (0.64) AURKARPS6KB1SLC7A5NOS3NOS1
SCHEMBL3050840 0.85 SLC7A5 (0.64) AURKARPS6KB1SLC7A5NOS3NOS1
Trifluoroacetic Acid SCHEMBL29643011 0.85 PDK1 (0.46) AURKARPS6KB1SLC7A5NOS3NOS1
SCHEMBL4184785 0.84 CYP17A1 (0.52) AURKARPS6KB1HDAC1HDAC3HDAC8
SCHEMBL29969056 0.84 AURKA (0.52) AURKARPS6KB1SIRT2HDAC1HDAC3
SCHEMBL165660 0.84 AURKA (0.52) AURKARPS6KB1SIRT2HDAC1HDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9988420-B2 Cytotoxic peptides and conjugates thereof NOVARTIS AG (CH) 2018-06-05 US disclosed